20-17227437-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_002594.5(PCSK2):​c.132C>G​(p.Asp44Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

PCSK2
NM_002594.5 missense

Scores

18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.524

Publications

0 publications found
Variant links:
Genes affected
PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03009978).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002594.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK2
NM_002594.5
MANE Select
c.132C>Gp.Asp44Glu
missense
Exon 1 of 12NP_002585.2
PCSK2
NM_001201528.2
c.75C>Gp.Asp25Glu
missense
Exon 2 of 13NP_001188457.1P16519-3
PCSK2
NM_001201529.3
c.132C>Gp.Asp44Glu
missense
Exon 1 of 11NP_001188458.1P16519-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK2
ENST00000262545.7
TSL:1 MANE Select
c.132C>Gp.Asp44Glu
missense
Exon 1 of 12ENSP00000262545.2P16519-1
PCSK2
ENST00000377899.5
TSL:1
c.75C>Gp.Asp25Glu
missense
Exon 2 of 13ENSP00000367131.1P16519-3
PCSK2
ENST00000947703.1
c.132C>Gp.Asp44Glu
missense
Exon 1 of 12ENSP00000617762.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461782
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111922
Other (OTH)
AF:
0.00
AC:
0
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
7.8
DANN
Benign
0.80
DEOGEN2
Benign
0.041
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.78
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.49
T
M_CAP
Benign
0.0040
T
MetaRNN
Benign
0.030
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-0.28
N
PhyloP100
0.52
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-0.010
N
REVEL
Benign
0.029
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.11
MutPred
0.20
Gain of ubiquitination at K40 (P = 0.0872)
MVP
0.11
MPC
0.14
ClinPred
0.035
T
GERP RS
1.9
PromoterAI
-0.032
Neutral
Varity_R
0.044
gMVP
0.18
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1383425066; hg19: chr20-17208082; API